IPP Bureau
Snapdeal to promote Ayushman Bharat Digital Mission’s Heath ID
By IPP Bureau - January 03, 2022
The Health ID will allow users to connect with different healthcare providers and enable a consent-based sharing of personal health records
U.S. FDA grants EUA for Pfizer-BioNTech booster for 12 years and older
By IPP Bureau - January 03, 2022
First emergency use authorization in the United States for a Covid-19 vaccine booster in adolescents 12 through 15 years of age
Tan Thanh Holdings to pre-purchase 10 million doses of Covid-19 oral vaccines for ASEAN region
By IPP Bureau - December 30, 2021
Oravax's oral VLP vaccine in development targets three SARS CoV-2 virus surface proteins, including proteins less susceptible to mutation, thus making the vaccine potentially more effective against current and future variants of the Covid-19 virus
Comar expands packaging solutions with Omega acquisition
By IPP Bureau - December 30, 2021
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
Quidel’s Antigen tests can detect Omicron variant
By IPP Bureau - December 30, 2021
The QuickVue antigen tests are able to detect the live Omicron variant with similar performance as with other variants
Biological E gets nod to study Corbevax as a booster dose
By IPP Bureau - December 30, 2021
The Subject Expert Committee has recommended grant of permission to conduct Phase 3 trials under certain conditions
VivaLyf Innovations to launch EzLyf, India's first non-invasive glucometer
By IPP Bureau - December 30, 2021
The glucometer connects to one’s smartphone and provides actionable diagnostic information
Green ChemisTree Foundation announces virtual conference on Innovations in Green & Sustainable Chemistry for Pharma Industry
By IPP Bureau - December 30, 2021
Aim of the virtual conference is to facilitate Indian Pharma Industry adopt Green & Sustainable Chemistry as a tool to enhance Economic & Environmental Competitiveness
Merck awarded €121 million contract for flow membrane production facility in Wisconsin, USA
By IPP Bureau - December 30, 2021
The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness
Granules receives ANDA approval for amphetamine mixed salts
By IPP Bureau - December 30, 2021
The current annual U.S. market for amphetamine mixed salts, USP 1.25mg, 1.875mg, 2.5mg, 3.125mg, 3.75mg, 5mg, 7.5mg immediate release tablets strengths is approximately US $ 335 million, according to MAT, Oct 2021 IQVIA/IMS Health
Siemens Healthineers receive EUA for Covid-19 antigen self-test
By IPP Bureau - December 30, 2021
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of Covid-19 exposure
Sanofi loses appeal in the US over Lantus device patents
By IPP Bureau - December 30, 2021
Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee
Study demonstrates Covaxin safe for kids in the age 2-18 years
By IPP Bureau - December 30, 2021
Covaxin has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study. Neutralizing antibodies in children on an average 1.7 times higher than in adults
Translumina to set up Asia's largest heart valve facility at AMTZ Vizag
By IPP Bureau - December 29, 2021
The facility at the Andhra Pradesh Medtech Zone is expected to be completed by Dec 2022
U.S. FDA approves Leo Pharma’s Adbry
By IPP Bureau - December 29, 2021
Adbry is the first biologic launched by LEO Pharma in the United States and is expected to be available in pharmacies by February 2022
